期刊文献+

肝脏局灶性病变的强化方式在其定性诊断中的价值 被引量:2

Value of Enhancement Patterns for Characterization of Focal Hepatic Lesions
暂未订购
导出
摘要 目的探讨肝脏局灶性病变(FHL)的强化方式在其定性诊断中的价值。方法前瞻性纳入47例FHL病例(50个病灶),采用MRI三维容积式内插值法屏气检查序列(3D-VIBE)对病灶进行包括动脉早期、动脉晚期和门静脉期在内的多期动态增强扫描,分析3D-VIBE序列所显示的病灶形态学特点和测量病灶的对比噪声比,重点观察病灶的强化方式和强化方式的动态演变过程。结果①17例(20个病灶)肝细胞肝癌(HCC)多表现为“动脉期快进、门静脉期快出”的强化方式,60%的HCC出现“假包膜”,65%合并肝硬变背景;②3例胆管细胞肝癌动脉期轻度强化,门静脉期及延迟期强化,67%合并有病灶周围近侧肝内胆管的扩张;③12个(100%)转移性肝癌均表现为周边程度不一的环形强化;④肝血管瘤在动脉早期边缘呈周边结节样强化,并随时间推移出现向心性的“推进式”强化;⑤4例细菌性肝脓肿主要表现为脓肿壁的簇状或环形强化和内部纤维分隔的轻度强化,1例嗜酸性肉芽肿仅轻度强化。结论FHL的形态学特征以及动脉期的强化特点和强化演变方式对定性诊断帮助较大;MRI3D-VIBE序列多期动态扫描是提供上述信息的最优影像学技术。 Objective To investigate the diagnostic value of the enhancement patterns for characterizing various focal hepatic lesions (FHL). Methods Forty-seven patients (50 lesions) were included into the study. The morphologic features and the dynamic enhancement patterns of FHL were observed in the early arterial phase, late arterial phase and portal venous phase. The degree of FHL enhancement was analyzed by calculating the contrast-to-noise ratio. Results 70% of the HCCs presented "fast-filling and rapid-washout" feature; 67% of the cholangiocarcinomas showed slight enhancement in arterial phase, and 33.3% had delayed enhancement on portal venous phase; All hemangiomas presented peripheral nodular enhancement in arterial phase, which then demonstrating centropedal "push-on" enhancement in portal venous phase; Hepatic abscesses mainly presented a slightly enhanced rim around the lesion with fibrous septa inside and an edematous zone outside. Conclusion The enhancement pattern and the dynamic evolution of FHL enhancement had a great diagnostic value for different FHL by using MRI 3D-VIBE sequence.
出处 《中国普外基础与临床杂志》 CAS 2006年第4期474-478,共5页 Chinese Journal of Bases and Clinics In General Surgery
关键词 肝脏局灶性病变 磁共振成像 三维容和式内插值法屏气检查 Focal hepatic lesion Magnetic resonance imaging 3D-VIBE
  • 相关文献

参考文献15

  • 1Hussain SM,Zondervan PE,IJzermans JN,et al.Benign versus malignant hepatic nodules:MR imaging findings with pathologic correlation[J].Radiographics,2002;22(5):1023
  • 2Lee VS,Lavelle MT,Rofsky NM,et al.Hepatic MR imaging with a dynamic contrast-enhanced isotropic volumetric interpolated breath-hold examination:feasibility,reproducibility,and technical quality[J].Radiology,2000;215(2):365
  • 3Semelka RC,Hussain SM,Marcos HB,et al.Perilesional enhancement of hepatic metastases:correlation between MR imaging and histopathologic findings-initial observations[J].Radiology,2000;215(1):89
  • 4Muramatsu Y,Takayasu K,Moriyama N,et al.Peripheral low-density area of hepatic tumors:CT-pathologic correlation[J].Radiology,1986;160(1):49
  • 5Kadoya M,Matsui O,Takashima T,et al.Hepatocellular carcinoma:correlation of MR imaging and histopathologic findings[J].Radiology,1992;183(3):819
  • 6Grazioli L,Olivetti L,Fugazzola C,et al.The pseudocapsule in hepatocellular carcinoma:correlation between dynamic MR imaging and pathology[J].Eur Radiol,1999;9(1):62
  • 7Ebara M,Ohto M,Watanabe Y,et al.Diagnosis of small hepatocellular carcinoma:correlation of MR imaging and tumor histologic studies[J].Radiology,1986;159(2):371
  • 8Itoh K,Nishimura K,Togashi K,et al.Hepatocellular carcinoma:MR imaging[J].Radiology,1987;164(1):21
  • 9Saitoh S,Ikeda K,Koida I,et al.Small hepatocellular carcinoma:evaluation of portal blood flow with CT during arterial portography performed with balloon occlusion of the hepatic artery[J].Radiology,1994;193(1):67
  • 10Dooms GC,Kerlan RK Jr,Hricak H,et al.Cholangiocarcinoma:imaging by MR[J].Radiology,1986;159(1):89

二级参考文献2

  • 1王建军,第二军医大学学报,1985年,6卷,239页
  • 2李美玲,中华放射学杂志,1984年,18卷,161页

共引文献49

同被引文献18

  • 1邬颖华,宋彬,徐隽,印隆林,毛芸.VIBE序列在原发性肝癌MRI诊断中的价值[J].中国普外基础与临床杂志,2005,12(2):184-187. 被引量:11
  • 2王化,王霄英,蒋学祥.3.0T MR全肝动脉期多时相增强扫描技术的初步应用[J].中国医学影像技术,2006,22(8):1210-1212. 被引量:21
  • 3朱晓梅,王德杭,李梅,唐立钧.造影剂到达腹主动脉的峰值大小与患者因素的关系[J].实用放射学杂志,2007,23(3):347-350. 被引量:8
  • 4Bouyn CI, Leclere J, Raimondo G, et al. Hepatic focal nodular hyperplasia in children previously treated for a solid tumor. Incidence, risk factors, and outcome [J]. Cancer, 2003; 97 (12) : 3107
  • 5Scalori A, Tavani A, Gallus S, et al. Risk factors for focal nodular hyperplasia of the liver: an Italian case-control study [J]. Am J Gastroenterol, 2002; 97(9):2371
  • 6Di Carlo I, Urrico GS, Ursino V, et al. Simultaneous occurrence of adenoma, focal nodular hyperplasia, and hemangioma of the liver: are they derived from a common origin? [J]. J Gastroenterol Hepatol, 2003; 18(2) : 227
  • 7Herman P, Pugliese V, Machado MA, et al. Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment [J]. World J Surg, 2000; 24(3):372
  • 8Luciani A, Kobeiter H, Maison P, et al. Focal nodular hyperplasia of the liver in men: is presentation the same in men and women? [J]. Gut, 2002; 50(6):877
  • 9Reddy KR, Kligerman S, Levi J, et al. Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome [J]. Am Surg, 2001;67(2): 173
  • 10Attal P, Vilgrain V, Brancatelli G, et al. Telangiectatic focal nodular hyperplasia: US, CT, and MR imaging findings with histopathologic correlation in 13 cases [J]. Radiology, 2003;228(2): 465

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部